The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide
about
Conceptualizing neurodevelopmental disorders through a mechanistic understanding of fragile X syndrome and Williams syndromeTargeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesTherapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and BackNormal Performance of Fmr1 Mice on a Touchscreen Delayed Nonmatching to Position Working Memory TaskBehavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background.From FMRP function to potential therapies for fragile X syndrome.Modeling fragile X syndrome in the Fmr1 knockout mouseGenetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS).Lithium: a promising treatment for fragile X syndrome.Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndromeGenetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice.Muscarinic cholinergic receptors modulate inhibitory synaptic rhythms in hippocampus and neocortexReversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.Do psychoactive drugs have a therapeutic role in compulsivity? Studies on schedule-induced polydipsia.Regulation of Phosphorylation of AMPA Glutamate Receptors by Muscarinic M4 Receptors in the Striatum In vivo.In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease.Of Men and Mice: Modeling the Fragile X Syndrome.
P2860
Q24613296-7E39B5F3-BCF0-4DDF-91E6-51F8B2AEC204Q27023257-5D6F2A5A-38DF-4FD5-B020-263A25C8E875Q27337360-B1A92891-7B79-4D07-BC45-60BAA4B98844Q30387508-C9F9F519-7982-4016-8DAA-0E342620D9FEQ30403591-A219FF66-3CB8-49E1-B1EB-54E54B1A2857Q30410502-FB58FD29-B0A3-42DB-A175-D5931192361DQ30420595-8997C388-DBA5-4179-9F5C-86582B2B15B3Q30457688-A92185F9-88E3-4659-9DE5-AF18EEC12D0CQ33777951-E8CFC729-9A0F-4681-A2BD-6F33D1DEF12FQ35035766-6436D5D3-7D6A-4867-95AD-5C43EBCAB328Q36342394-AB69CBF5-3E9D-4C31-900E-6CD7D8870D4FQ38253634-9CF70843-A2FE-435A-A2EC-DF971926A10DQ42512974-2D0A3A54-8D8E-4416-8D9A-2B9017C962EEQ47192906-2FD268E4-FB9F-482F-B578-0BAFA8EBCF4EQ50060348-267F2C28-5F56-4CC4-A85E-7BEFF404765DQ52665081-B5D12DAB-ACE9-46D2-9007-24C7559E72F5Q53422584-8C74BC27-BD4A-40AA-922A-DEE5473EB53A
P2860
The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide
@ast
The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide
@en
type
label
The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide
@ast
The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide
@en
prefLabel
The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide
@ast
The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide
@en
P2093
P2860
P356
P1476
The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide
@en
P2093
Jennie R Perkins
Lisa A Yuva-Paylor
Nghiem Bui
Richard Paylor
Surabi Veeraragavan
P2860
P304
P356
10.1037/A0025202
P577
2011-10-01T00:00:00Z